Osaka, Japan

Keisuke Jinbo



 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keisuke Jinbo: Innovator in Rocuronium Preparations

Introduction

Keisuke Jinbo is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of rocuronium preparations. With a total of 2 patents, his work focuses on improving the stability and reducing the pain associated with these preparations.

Latest Patents

Jinbo's latest patents include a rocuronium preparation with improved stability. This invention provides a formulation that contains rocuronium and a buffer solution, adjusted to a pH of 3.5 or less. The buffer solutions can include citric acid-sodium hydroxide, tartaric acid-sodium hydroxide, and others. This preparation demonstrates excellent stability, with a generation rate of rocuronium-related substance C of 5% or less after six months of storage at 40°C.

Another significant patent by Jinbo is a rocuronium preparation designed to reduce vascular pain. This formulation also contains rocuronium and a buffer solution, with a titratable acidity of 100 mEq or less. The buffer solutions may include acetate, citrate, formate, and others, aimed at alleviating pain during administration.

Career Highlights

Keisuke Jinbo is associated with Maruishi Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in enhancing the efficacy and safety of rocuronium preparations.

Collaborations

Jinbo has collaborated with notable colleagues, including Yutaka Itsuji and Hironori Nagahara. Their combined expertise has contributed to the advancements in the formulations they have developed.

Conclusion

Keisuke Jinbo's contributions to the field of pharmaceuticals, particularly in the area of rocuronium preparations, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to enhancing the stability and reducing the pain associated with these important medical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…